# Coultreon Biopharma funding rounds and investors

As of 14 Oct 2026, Coultreon Biopharma has raised $125M across 1 verified round on record; latest: $125 million Series A led by Forbion, Novo Holdings and 1 other, announced 28 Apr 2026.

Develop autoimmune disease treatments

Website: https://coultreon.com  
Headquarters: Leuven, Belgium  
Page: https://fireround.dev/companies/coultreon-biopharma

## Verified rounds

| Announced | Round | Amount | Lead investors | Other investors | Sources |
| --- | --- | --- | --- | --- | --- |
| 2026-04-28 | Series A | $125 million | Forbion, Novo Holdings, Sofinnova Partners | Balyasny Asset Management, Finchley Healthcare Ventures, Galapagos, Longwood Fund, Luma Group, Regeneron Ventures, Samsara BioCapital | [coultreon.com](https://www.coultreon.com/news/coultreon-biopharma-raises-125-million-series-a), [globenewswire.com](https://www.globenewswire.com/news-release/2026/04/28/3282440/0/en/coultreon-biopharma-raises-125-million-in-series-a-financing-to-advance-immunology-pipeline.html), [clinicaltrialvanguard.com](https://www.clinicaltrialvanguard.com/news/coultreon-biopharma-raises-125m-for-immunology-pipeline) |

Source: Fireround (https://fireround.dev), an open-source funding feed. Each round is checked against the pages listed with it.